🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was conducted in order to evaluate the efficacy and safety of th...
Status
Completed
Location
Medizinische Universität Salzburg - Universitätsklinik für Innere Medizin III
Start Date
2007-05
Trial ID
NCT00523159
Treatments Being Tested
The primary objective was to estimate the proportion of participants with d...
Status
Completed
Location
Research Site
Start Date
2014-04-07
Trial ID
NCT02014441
Treatments Being Tested
This study will evaluate the safety and feasibility of administering a pept...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2007-06
Trial ID
NCT00674791
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Status
Completed
Location
Site 2644 University of California, Irvine
Start Date
2018-06-19
Trial ID
NCT03294083
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-10-28
Trial ID
NCT00070070
Treatments Being Tested
Goal: To characterize the cellular events that occur in vivo after vaccinat...
Status
Completed
Location
University of Virginia
Start Date
2004-06
Trial ID
NCT00912574
Treatments Being Tested
Primary Objectives: 1. To determine the efficacy of in vivo purging achiev...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-01
Trial ID
NCT00499343
This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Status
Terminated
Location
Ottawa Hospital and Research Institute (OHRI)
Start Date
2011-10
Trial ID
NCT01329809
Treatments Being Tested